Table 3 Biological process of GO analysis.

From: Network pharmacology-based investigation of the pharmacological mechanisms of diosgenin in nonalcoholic steatohepatitis

ID

Biological process

P value

Fold enrichment

FDR

GO:0031281

Positive regulation of cyclase activity

9.97E−05

170.8672566

0.001967972

GO:0070141

Response to UV-A

9.97E−05

170.8672566

0.001967972

GO:1,901,687

Glutathione derivative biosynthetic process

1.99E−04

128.1504425

0.003474314

GO:0045923

Positive regulation of fatty acid metabolic process

3.30E−04

102.520354

0.005161332

GO:0070857

Regulation of bile acid biosynthetic process

3.30E−04

102.520354

0.005161332

GO:0010887

Negative regulation of cholesterol storage

2.70E−09

93.2003218

3.12E−07

GO:0061419

Positive regulation of transcription from RNA polymerase II promoter in response to hypoxia

4.93E−04

85.43362832

0.007379709

GO:0033591

Response to L-ascorbic acid

6.87E−04

73.22882427

0.009747128

GO:0046321

Positive regulation of fatty acid oxidation

6.87E−04

73.22882427

0.009747128

GO:0060336

Negative regulation of Interferon-gamma-mediated signaling pathway

9.13E−04

64.07522124

0.012266478